NEU neuren pharmaceuticals limited

M&A, page-105

  1. 2,759 Posts.
    lightbulb Created with Sketch. 1062
    Fordy - nothing is 'holding us back'. We do not need a licencing deal to progress 2591 at this stage, as we have all the cash we need. Management has also stated that they think licencing 2591 out (something they don't even need to be thinking about for a looong time) is a boring option.

    Any 'licencing' deal is likely to be worth much more post positive Ph3 results regardless and I for one would want management to wait on these results before considering any such deal vs a takeover or M&A.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.